Our key R&D Activities include
Product Development
We focus on development of viable chemical routes for pharmaceuticals and intermediates. The
activities involves conceptualization of the product, route selection, execution
and finally delivery of the samples and approval from customer leading to a bulk
order.
An open two-way dialogue with the customer at various stages with unwavering focus on quality at appropriate cost ensures that we deliver an optimal solution within the agreed timeline.
Several product development groups each consisting of 3-4 chemists and a group leader, work towards effective development of a product once it has been screened though the “Stage Gate” methodology.
NCE Development Support
Novodigm’s support for NCE development activities by several Global
Pharmaceutical majors, adds to the confidence of our R&D team which looks
forward to be a partner in your NCE development programme.
Total confidentiality through secrecy agreement, quick response for multi gram to multi kilogram delivery of advanced intermediates and willingness to work with emerging product chemistry attributes, has helped us forge long-term and mutually rewarding business relationships.
Analytical Development
The product & process development is supported by full-fledged analytical
section with in-house & corporate R&D lab facilities which includes HPLC, GC,
Polarimeter, FTIR, UV VIS Spectrophotometer, LC-MS, GC-MS, NMR, DSC, TGA, CHN,
XRD etc.
The capability encompasses analytical method development for new products and also validation
of in-house analytical methods and integration of customers' analytical methods
with our SOPs. This team also supports QC for in-process testing and other
process development & validation initiatives by R&D team.
Small Volume Manufacturing
Novodigm also has reactors of up to 20 liters capacity, and other associated
equipment. It is utilized both for scale up studies on the in-house developed
products & processes as well for manufacture of 5- 10 kg of high value
intermediates.
We, at Novodigm Limited, therefore can partner with you at different stages of your drug development process – from pre-clinical to Phase I-III trials, and later for your commercial quantity needs.

